Clinical Trials in Boston

Showing 11461-11480 of 17,836 trials

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

NCT02285920

The SPin-D Trial is a phase II randomized, double-blind, placebo-controlled, multi-center study of spironolactone (SPL) for patients with hemodialysis-dependent end-stage renal disease.

End-Stage Renal Disease

University of Pennsylvania129 participantsStarted Nov 2014

Washington D.C., District of Columbia, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +1 more locations

COMPLETEDPhase 1/2< 1 mile

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

NCT01638936

The purpose of this study is to test safety and anti-tumor activity of BT062 in combination with lenalidomide and dexamethasone to define the best doses for treating patients with relapsed and refractory multiple myeloma.

Multiple Myeloma

Biotest Pharmaceuticals Corporation64 participantsStarted Jul 2012

Duarte, California, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +7 more locations

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Find Trials by Condition in Boston

Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps

Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Consumption of Potatoes, Avocados and Chickpeas and Cognitive Function in Older Adults

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Study of Mepolizumab Safety Syringe in Asthmatics

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection